Drugs & TargetsFree Novartis’ Kymriah gets second FDA approval—for large B-cell lymphoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree FDA approves Tafinlar and Mekinist for BRAF V600-mutant melanoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree FDA grants priority review to cemiplimab in advanced cutaneous squamous cell carcinoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree Genocea files IND for neoantigen cancer vaccine candidate GEN-009 May 04, 2018Vol.44 No.18
Drugs & TargetsFree Mylotarg approved in EU for previously untreated, de novo, CD33-positive AML in combination with Chemotherapy April 27, 2018Vol.44 No.17
Drugs & TargetsFree Nektar, Takeda to evaluate combining CD122-biased agonist and dual SYK and FLT-3 inhibitor April 27, 2018Vol.44 No.17
Drugs & TargetsFree Pfizer gets Complete Response Letter for trastuzumab biosimilar April 27, 2018Vol.44 No.17
Drugs & TargetsFree FDA approves Tagrisso for front-line metastatic NSCLC with common EGFR mutations April 20, 2018Vol.44 No.16
